Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 108 entries
View as:

The BARCODE 1 Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT03158922 Org: User:
Start: 04/29/16 End: 12/31/28 Due: 12/31/29

The BARCODE 2 Study - the Use of Genetic Profiling to Guide Prostate Cancer Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02955082 Org: User:
Start: 05/25/17 End: 09/30/25 Due: 09/30/26

Study of Weekly Radiotherapy for Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01810757 Org: User:
Start: 04/30/14 End: 01/31/25 Due: 01/31/26

Leucovorin and Fluorouracil Compared With Observation in Treating Patients With Colorectal Cancer That Has Been Surgically Removed

Phase: N/A Priority: Normal
NCT ID: NCT00005586 Org: User:
Start: 10/31/97 End: - Due: -

POTENT - Tepotinib in Combination with Pembrolizumab in NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT05782361 Org: User:
Start: 05/03/23 End: 02/01/28 Due: 02/01/29

Radiation Therapy in Women With Low Risk Early-Stage Breast Cancer Who Have Undergone Breast Conservation Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00814567 Org: User:
Start: 05/03/07 End: 09/30/20 Due: 09/30/21

A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT03145961 Org: User:
Start: 12/21/17 End: 03/31/24 Due: 03/31/25

Evolution of Resistance to Systemic Therapies in Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02257775 Org: User:
Start: 05/11/15 End: 11/23/17 Due: 11/23/18

Phase I Trial of Defactinib and VS-6766.

Phase: N/A Priority: Normal
NCT ID: NCT03875820 Org: User:
Start: 12/12/17 End: 10/31/23 Due: 10/31/24

The COherence of Scatter Identification and Exclusion Algorithm Study

Phase: N/A Priority: Normal
NCT ID: NCT06975579 Org: User:
Start: 08/27/24 End: 06/30/25 Due: 06/30/26

Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06976892 Org: User:
Start: 05/31/25 End: 12/31/29 Due: 12/31/30

Feasibility Study Testing Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects

Phase: N/A Priority: Normal
NCT ID: NCT02780375 Org: User:
Start: 09/12/16 End: 07/17/18 Due: 07/17/19

Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00079248 Org: User:
Start: 03/31/02 End: - Due: -

Exploring the Mechanisms and Dynamics of Clonal Evolution Leading to Recurrence in Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04686188 Org: User:
Start: 11/26/20 End: 09/01/22 Due: 09/01/23

Hypofractionated Expedited Radiotherapy for Men With localisEd proState Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04595019 Org: User:
Start: 07/29/21 End: 04/30/28 Due: 04/30/29

Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations

Phase: N/A Priority: Normal
NCT ID: NCT02705846 Org: User:
Start: 09/30/14 End: 12/31/35 Due: 12/31/36

CORONADO (Circulating tumOur pROtein quaNtification cApillary blooD cOvid-19)

Phase: N/A Priority: Normal
NCT ID: NCT04659252 Org: User:
Start: 03/04/21 End: 12/01/21 Due: 12/01/22

A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT

Phase: N/A Priority: Normal
NCT ID: NCT05613023 Org: User:
Start: 09/09/22 End: 06/30/30 Due: 06/30/31

The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00261456 Org: User:
Start: 03/31/05 End: 02/28/30 Due: 02/28/31

Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03506997 Org: User:
Start: 11/27/18 End: 09/01/25 Due: 09/01/26

Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects (RTGene 2)

Phase: N/A Priority: Normal
NCT ID: NCT03809377 Org: User:
Start: 05/09/19 End: 06/01/26 Due: 06/01/27

A Phase II Trial of Vinflunine Chemotherapy in Locally-advanced and Metastatic Carcinoma of the Penis (VinCaP)

Phase: N/A Priority: Normal
NCT ID: NCT02057913 Org: User:
Start: 03/17/14 End: 11/06/18 Due: 11/06/19

PRIMER: Development of Daily Online Magnetic Resonance Imaging for Magnetic Resonance Image Guided Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02973828 Org: User:
Start: 10/17/17 End: 12/31/26 Due: 12/31/27

A Phase II Study of Axitinib in Patients With Metastatic Renal Cell Cancer Unsuitable for Nephrectomy

Phase: N/A Priority: Normal
NCT ID: NCT01693822 Org: User:
Start: 10/31/12 End: 02/28/22 Due: 02/28/23

Magnetic Resonance Imaging Screening in Li Fraumeni Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01737255 Org: User:
Start: 10/31/12 End: 12/31/17 Due: 12/31/18